Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer, effective Feb. 15. She succeeds longtime CEO Maryann Roefaro, who is retiring from the position ...

About 100 students from Apollo High School will raise money for cancer treatment Sunday, when the students hold their annual DanceBlue Marathon from 4 p.m. to midnight at AHS.

ADRP Advisory Board Member Amanda Hess discusses advances in transfusion medicine, challenges blood centers face, and how ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

St. Francis Hospital’s internal medicine residency program received its first fellowship training matches. MD, MSC Andrew ...

Sikander Ailawadhi, MD, discusses how the 2024 ASH Annual Meeting’'s study on “"Hematologists’' Approach to Discussing Older Patients’ Values in the Context of Allogeneic Hematopoietic Cell ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...

Kite Pharma is flying high with the addition of a new member to its senior leadership team. | Kite Pharma is flying high with ...

The American Cancer Society projected approximately 2 million new cancer diagnoses and 618,000 new cancer deaths in the U.S.

The global hematology diagnostic market is projected to grow from USD 780.0 million in 2023 to USD 2.0 billion by 2033, at a ...